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In the present study the lysophospholipid sources for arachidonic (AA) and eicosapentaenoic acid (EPA) incorporation into and redistribution within the phospholipids of phorbol-ester-differentiated U937 cells was investigated. Initially, AA incorporated primarily into choline glycerophospholipids (PC), whereas EPA incorporated mainly into ethanolamine glycerophospholipids (PE). Bromoenol lactone (BEL), an inhibitor of the Group VI Ca# + -independent phospholipase A # (iPLA # ), diminished both lysophosphatidylcholine levels and the incorporation of AA into phospholipids. However BEL had little effect on EPA incorporation. In concanavalin A-activated cells, EPA, but not AA, incorporation was also affected by methyl arachidonyl fluorophosphonate (MAFP), suggesting an additional role for the group IV cytosolic phospholipase A # . In the activated cells AA and EPA did not compete with each other for incorporation, indicating that the pathways for AA and EPA incorporation are
INTRODUCTION
Availability of free arachidonic acid (AA) is widely recognized as a rate-limiting step in the formation of prostaglandins by activated cells [1] . This fatty acid is an intermediate in a reacylation\deacylation cycle of membrane phospholipids, the so-called ' Lands pathway ', in which the fatty acid is cleaved from phospholipid by phospholipase A # (PLA # ) and reincorporated by acyltransferases [2] [3] [4] . Whereas in resting cells reacylation dominates, in stimulated cells the dominant reaction is the deacylation. Nevertheless, increased AA reacylation during cellular activation is still very significant, as manifested by the fact that only a minor portion of the free AA released by PLA # is converted into eicosanoids, the remainder being effectively incorporated back into phospholipids [2] [3] [4] .
AA incorporation into phospholipids is critically dependent on the availability of lysophospholipid acceptors, particularly lysophosphatidylcholine (lysoPC). In many cells, the levels of lysoPC appear to be maintained by the continuing action of the Ca# + -independent Group VI phospholipase A # (iPLA # ) on cellular phospholipids [5] . Thus a decrease in the activity of the iPLA # frequently results in the diminished production of lysoPC [6] [7] [8] [9] [10] [11] and hence in the inhibition of AA incorporation into phospholipids [6] [7] [8] [9] [10] .
Once the AA is initially incorporated into lysoPC by the action of CoA-dependent acyltransferases, it is transferred to certain lysophospholipids, particularly the ethanolamine lysophospholipids (lysoPE). Such a transfer is catalysed by the enzyme CoAAbbreviations used : AA, arachidonic acid ; Con A, concanavalin A ; EPA, eicosa-5,8,11,14,17-pentaenoic acid ; PLA 2 , phospholipase A 2 ; cPLA 2 , cytosolic phospholipase A 2 ; iPLA 2 , Ca 2 + -independent phospholipase A 2 ; sPLA 2 , secretory phospholipase A 2 ; CoA-IT, CoA-independent transacylase ; BEL, bromoenol lactone [(E )-6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one] ; MAFP, methyl arachidonyl fluorophosphonate ; IHP, diethyl 7-(3,4,5-triphenyl-2-oxo-2,3-dihydroimidazol-1-yl)hepatine phosphonate (SK&F 98625) ; LY311727, 3-(3-acetamide-1-benzyl-2-ethylindolyl-5-oxy)propanesulphonic acid ; PC, choline glycerophospholipids ; PE, ethanolamine glycerophospholipids ; PI, phosphatidylinositol. 1 This work is dedicated to the memory of Bele! n Ferna! ndez-Boya. 2 e-mail jbalsinde!ibgm.uva.es partially different. The AA and EPA initially incorporated into PC slowly moved to PE in a process that took several hours. The transfer of AA and EPA from PC to PE was not inhibited by BEL, MAFP or LY311727 [3-(3-acetamide 1-benzyl-2-ethylindolyl-5-oxy)propanesulphonic acid], raising the possibility that an as-yet-undetermined phospholipase A # may be involved in fatty acid phospholipid remodelling. A strong candidate to be involved in these reactions is a novel Ca# + -independent phospholipase A # that, unlike all known iPLA # s, is resistant to inhibition by BEL and also to MAFP and LY311727. The enzyme activity cleaves both PC and PE and is thus able to provide the lysoPC and lysoPE acceptors required for the fatty acid acylation reactions.
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independent transacylase (CoA-IT) [12] . Thus, for the AA to be efficiently incorporated into phospholipids, two kinds of lysophospholipid acceptors should be readily available (Scheme 1). The provider of the lysoPE acceptors for the CoA-IT reaction is assumed to be a PLA # [12, 13] , but its identity has not been elucidated.
U937 cells are derived from a human histiocytic lymphoma and differentiate into macrophage-like cells when treated with phorbol esters such as PMA [14, 15] . The objective of the present study was to understand better the biochemical features of AA 
Cell culture
U937 cells were maintained in RPMI 1640 medium supplemented with 10 % (v\v) fetal-calf serum, 2 mM glutamine, penicillin (100 units\ml) and gentamycin (24 µg\ml). The cells were incubated at 37 mC in a humidified atmosphere of CO # \O # (1 : 19) at a cell density of (0.5-1)i10' cells\ml in 12-well plastic culture dishes (Costar). Cell differentiation was induced by treating the cells with 35 ng\ml PMA for 24 h [14, 15] .
Measurement of [ 3 H]AA incorporation into phospholipids
The PMA-differentiated U937 cells were placed in serum-free medium for 60 min before exposure to exogenous [$H]AA (5 nM ; 0.5 µCi\ml). At the indicated times, supernatants were removed and the cell monolayers were scraped twice with 0.1 % Triton X-100. Total lipids were extracted and were separated by TLC with n-hexane\diethyl ether\acetic acid (70 : 30 : 1, by vol.). For separation of phospholipid classes, a mobile phase consisting of chloroform\methanol\acetic acid\water (25 : 20 : 3 : 0.3, by vol.) was used. This system allows a good resolution between major phospholipids, including phosphatidylinositol (PI) and phosphatidylserine (PS).
Measurement of [ 3 H]fatty acid phospholipid remodeling
For these experiments, the PMA-differentiated U937 cells were pulse-labelled with [$H]AA or [$H]EPA (5 nM ; 0.5 µCi\ml) for 30 min at 37 mC. The cells were then washed four times with medium containing 1 mg\ml BSA to remove the non-incorporated label. Afterward the cells were placed in serum-free medium and incubated at 37 mC for the indicated periods of time, and in the absence or presence of the indicated compounds. The lipids were extracted and separated as described above.
Fatty acid release experiments
The cells were labelled with 0.5 µCi\ml [$H]AA or [$H]EPA for 18 h. After this period, the cells were washed and placed in serumfree medium for 1 h before the addition of 50 µg\ml concanavalin A (Con A) in the presence of 0.5 mg\ml BSA. The supernatants were removed, cleared of cells by centrifugation, and assayed for radioactivity by liquid scintillation counting.
Lysophospholipid determination
Cells labelled with 0.5 µCi\ml [$H]choline or [$H]ethanolamine for 2 days were used. After the incubations, lipids were extracted with ice-cold butan-1-ol and separated by TLC with chloroform\ methanol\acetic acid\water (50 : 40 : 6 : 0.6, by vol.) as a solvent system. Spots corresponding to lysoPC or lysoPE were scraped into scintillation vials and the amount of radioactivity was estimated by liquid scintillation counting.
iPLA 2 assay
Briefly, aliquots of PMA-treated U937 cells were incubated for 30 min at 37 mC in 100 mM Hepes, pH 7.5, containing 5 mM EDTA and 100 µM phospholipid substrate (pH 7.5), in a final volume of 250 µl. The substrates utilized in the assay were [$H]AA-labelled PC and [$H]AA-labelled PE, and they were used in the form of sonicated vesicles in buffer. Alternatively, iPLA # activity was also assayed toward a substrate in the form of mixed micelles of Triton X-100\phospholipid at a molar ratio 4 : 1. This was carried out exactly as described by Balsinde et al. [6] .
Preparation of labelled substrates for the iPLA 2 assay
[$H]AA-labelled PC and PE were isolated from cellular lipids of U937 cells incubated for 24 h with the corresponding exogenous fatty acids (0.5 µCi\ml). Labelled phospholipids were purified by TLC and tested for purity as described previously [17] .
Data presentation
Assays were carried out in duplicate or triplicate. Each set of experiments was repeated at least three times with similar results. Unless otherwise indicated, the data presented are from representative experiments.
RESULTS

Incorporation of AA and EPA into U937 cell phospholipids
When PMA-differentiated U937 cells were exposed to exogenous [$H]AA, it was rapidly incorporated into phospholipids ( Figure  1A ). This process was blunted by the presence of the iPLA # inhibitor BEL in the incubation medium ( Figure 1A Reduction of fatty acid incorporation by iPLA # inhibition is thought to reflect the diminished availability of lysoPC acceptor (Table 1) . These results are similar to those previously reported in mouse peritoneal macrophages [18] and thus support the existence in PMAdifferentiated U937 cells of specific systems for the uptake and acylation of C #! polyunsaturated fatty acids.
Fatty acid incorporation into the phospholipids of activated cells
For these experiments, the PMA-differentiated U937 cells were stimulated by 50 µg\ml Con A [14, 15] (Table 2) , which is in agreement with previous reports on other cell types [19] [20] [21] [22] . Pretreatment of the cells with BEL resulted in an expected decrease of the incorporation of both fatty acids into phospholipids (Table 2) . Importantly, addition of the dual cPLA exogenous fatty acid. Stimulation of the [$H]AA-labelled PMAdifferentiated cells with Con A resulted in a significant release of radiolabel to the incubation medium (Figure 2A ). Such a release was inhibited by MAFP, but not by BEL, suggesting that, in common with many other cells of myelomonocytic origin [23] [24] [25] [26] [27] [28] , it is cPLA # , not iPLA # , that is the enzyme responsible for the release (Figure 2A) .
Fatty acid release from U937 cell phospholipids
When the experiments were conducted in the presence of excess unlabelled AA, the release of endogenous [$H]AA was appreciably increased ( Figure 2B 
Fatty acid redistribution within phospholipids
In the following series of experiments, the redistribution of AA and EPA among phospholipids was examined. For these studies, the cells were pulse-labelled with The redistribution of AA and EPA from PC to PE is a hallmark of the CoA-IT-driven phospholipid remodelling [12] , and, as such, was significantly inhibited by the specific inhibitor IHP [16] (Table 3) . CoA-IT catalyses the CoA-independent transfer of AA from a phospholipid donor (AA-containing PC) to a lysophospholipid acceptor (usually lysoPE, acyl and alkenyl species) [12, 13] . To study the origin of the lysophospholipid acceptors used in the CoA-IT-driven reaction, the cells were incubated with different PLA # inhibitors during the 8 h remodell- ing period. The inhibitors used were the iPLA # inhibitor BEL (up to 25 µM), the dual iPLA # \cPLA # inhibitor MAFP (up to 25 µM) and the secretory PLA # inhibitor LY311727 (up to 50 µM). None of those compounds exerted a significant effect on the movement of [$H]AA or [$H]EPA from PC to PE (Table 3) . No known mammalian form of PLA # is resistant to all the three PLA # inhibitors listed in Table 3 [32, 33] . Hence, if the provider of lysoPE for the CoA-IT-catalysed reaction is a PLA # , it must be of an as-yet-undescribed type.
Identification of U937 cell iPLA 2 activity
Figure 4(A) shows that, when using [$H]AA-containing PC as a substrate, the PMA-differentiated U937 cells exhibited significant iPLA # activity that could be inhibited by BEL in a dose-dependent manner. Interestingly, a significant portion of the iPLA # activity (40-50 %) was found to be resistant to BEL. This suggests that PMA-differentiated U937 cells express both BEL-sensitive and -insensitive iPLA # activities. This is a striking finding, in view of previous reports showing that all iPLA # types cloned so far are completely supressed by BEL [34] [35] [36] [37] and that enzymic assays utilizing whole-cell homogenates have generally shown that virtually all the measurable iPLA # activity is BEL-sensitive [6, [38] [39] [40] [41] [42] . As a positive control for the results shown in Figure  4 (A), iPLA # assays were conducted under conditions that duplicated those used in [6] to demonstrate complete inhibition of cellular iPLA # activity by BEL in homogenates from P388D " macrophages. Specifically, iPLA # was measured toward a substrate in the form of mixed micelles of Triton X-100\phospholipid at a molar ratio 4 : 1 [6] . Under these conditions, the iPLA # activity measured was 3-5-fold lower than that observed toward pure phospholipid vesicles. Inclusion of 25 µM BEL in the assay mixture resulted in a 40-50 % inhibition, which is consistent with the results obtained with the vesicle assay. Thus, regardless of the assay system utilized, substantial BEL-independent iPLA # activity could be observed in the U937 cell homogenates. Replacing the EDTA by CaCl # (2 mM) in both the vesicle and the mixedmicelle assays increased PLA # activity by 1.5-2-fold. Figure 4(B) shows the iPLA # activity of PMA-differentiated U937 cells as assayed towards [$H]AA-containing PE. Inhibition in the presence of BEL was again detected, although in this case the majority of the activity was BEL-independent. Thus PMAdifferentiated U937 cells possess the capacity to generate significant amounts of lysoPE in a BEL-independent manner. Importantly, inclusion of MAFP or LY311727 in the assays had no measurable effect on enzyme activity. When similar studies were conducted with [$H]EPA-containing PC and PE and substrates, the results were essentially the same as those shown in Figure 4 (results not shown).
DISCUSSION
Unlike saturated fatty acids, AA and other polyunsaturated fatty acids such as EPA do not generally enter cellular phospholipids via direct acylation of glycerol phosphate\dihydroxyacetone or lysophosphatidic acid (i.e. the de no o pathway), but rather do it at a later stage, via direct acylation of pre-existing lysophospholipid acceptors. Since lysophospholipids are produced by the hydrolytic action of PLA # on phospholipids, this class of enzymes necessarily play a key role in AA incorporation into phospholipids.
Previous studies demonstrated that AA incorporation into the phospholipids of murine peritoneal macrophages does not require Ca# + , which suggested the involvement of an iPLA # -like activity [22] . Such an activity was later identified to belong to the Group VI iPLA # in studies carried out with the P388D " macrophage-like cell line [6, 7] . These findings were later confirmed by several workers in human neutrophils [8] , rat submandibular ductal cells [9] and rat uterine stromal cells [10] . Importantly, however, the contribution of Group VI iPLA # to maintaining the lysophospholipid pool that facilitates AA incorporation appears to largely depend on cell type. On the basis of BEL inhibition studies, the iPLA # contribution ranges from $ 90 % in rat submandibular ductal cells [9] , 50-60 % in phagocytic cells [6] [7] [8] to only 20-25 % in rat uterine stromal cells [10] . Altogether, these findings suggest that, in addition to the contribution of the iPLA # , the cells possess other mechanisms to generate and maintain the appropriate levels of lysophospholipid acceptors. This notion was highlighted by a recent report in rat pancreatic islets [11] , where iPLA # inhibition by BEL did not result in diminished AA incorporation into phospholipids. Rat pancreatic islets, however, maintain cellular lysophospholipid levels at very high levels and, unlike submandibular ductal cells, macrophages, neutrophils and stromal cells, AA incorporation in these cells depends on Ca# + [11] . These two differential findings might help to explain why the iPLA # appears not to play a role in AA incorporation into islet phospholipids. Nevertheless, iPLA # is estimated to contribute to at least 25 % of the very high steady-state lysophospholipid levels in pancreatic islets [11] . This suggests that, despite the apparent lack of involvement of Group VI iPLA # in AA incorporation reactions in these cells, and in addition to any as-yet-unclear signalling role [43] , the enzyme still plays a significant housekeeping role in islets.
In an attempt to gain further insight into the mechanisms regulating lysophospholipid levels in phagocytic cells, the features of AA incorporation into and remodelling within the phospholipids of PMA-differentiated U937 cells have been studied and compared with those of EPA. U937 cells are derived from a histiocytic lymphoma and differentiate into macrophage-like cells when treated with PMA [14, 15] [47] . The present data indicate that, in these cells, AA incorporation into phospholipids of both resting and Con A-activated, PMAdifferentiated U937 cells exhibits features that are similar to those of other phagocytic cells such as P388D " macrophages and neutrophils [6-8], i.e. it is Ca# + -independent and BEL-inhibitable. Importantly, BEL reduces AA incorporation only partially, suggesting the existence of Ca# + -independent pathway(s) for AA incorporation into phospholipids that may not involve the BELsensitive Group VI iPLA # . The above view is further supported by the experiments studying the incorporation of EPA into phospholipids. While Ca# + -independent EPA incorporation is only marginally affected by BEL. EPA is preferentially incorporated into PE over PC, which is at variance with the profile of AA incorporation. However, both fatty acids compete with each other for incorporation into the phospholipids of resting cells, indicating that the two fatty acids share, at least in part, a common pathway for incorporation. This situation contrasts with the one seen in Con A-activated cells, where AA and EPA do not compete with each other for incorporation into phospholipids. Of note, EPA incorporation into the phospholipids of activated cells is sensitive to MAFP, suggesting the involvement of Group IV cPLA # in the process. It is therefore likely that the increased lysophospholipid availability produced as a consequence of the stimulus-induced cPLA # activation plays a role in EPA incorporation. In accord with this, the PE pools appear to be preferential targets for cPLA # phospholipolysis in stimulated phagocytes [23, 48] . On the other hand, the stimulated incorporation of AA still occurs preferentially into PC and is MAFP-independent. Thus cPLA # would provide an additional supply of lysoPE acceptors to be used by EPA, but not by AA, and the existence of such an alternative route for EPA incorporation may explain why, in the activated cells, EPA does not compete with AA. Whether such a difference also reflects the involvement of other systems, such as acyl-CoA transferases specific for ωk3 versus ωk6 fatty acids [2, 49] , is unknown at present and will be the subject of future studies.
After the initial incorporation of AA mostly into PC, a slow transfer of the fatty acid occurs towards PE. Despite PE being already the major EPA-containing phospholipid at the beginning of the incubations, a transfer of EPA from PC to PE is observed as well. These changes have been well documented in other cell systems and reflect the remodelling action of the CoA-IT on cellular phospholipids [12] .
A PLA # is strikingly involved in the CoA-IT-driven remodelling reactions by providing the lysoPE acceptors utilized in the transacylation reaction [12, 13] . In the present study the nature of such a PLA # was investigated by measuring the transfer of AA and EPA from PC to PE in the presence of different PLA # inhibitors. However, none of the inhibitors tested, i.e. BEL, MAFP and LY311727, exert any detectable effect on the response. This unexpected finding suggests that the PLA # involved in this pathway may not be any of the previously identified PLA # types [32, 33] , and is in accord with a recent report in peripheralblood T lymphocytes [50] . The Ca# + -independent nature of the response strongly suggests the role of an iPLA # -like activity, different from the Group VI enzyme. Lysophospholipid sources for fatty acid esterification
In keeping with the above notion, studies with cell homogenates have revealed that iPLA # activity of PMA-differentiated U937 cells exhibits a significant component that is resistant to BEL, and this component is more evident when PE is used as a substrate for the assay. This finding is consistent with the possibility that the BEL-insensitive iPLA # activity of PMAdifferentiated U937 cells prefers PE over PC. It is noteworthy that the incorporation of EPA into phospholipids is only slightly affected by BEL and that this fatty acid is incorporated mainly into PE lipids. If a PE-preferring iPLA # were to mediate most of the incorporation of EPA into phospholipids, one would expect the production of lysoPE to be essentially BEL-independent, as indeed it is. Altogether, the results stress that the PMA-differentiated U937 cells contain a distinctive PLA # -like activity capable of generating lysophospholipid acceptors for incorporation into, and remodelling among, phospholipids under conditions where all other known PLA # s are not involved. Clearly, much work is yet to be done to clarify the mechanisms responsible for lysophospholipid level maintenance, but the current studies have begun to dissect the pathways and enzymes involved, and provide the fundamentals for future research aimed at understanding the role of this novel iPLA # -like activity in cellular phospholipid homoeostasis.
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